(Q36694476)

15 August 2017

Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanoma (English)

1 reference

15 August 2017

N Soufir

1

1 reference

15 August 2017

J J Lacapere

2

1 reference

15 August 2017

G Bertrand

3

1 reference

15 August 2017

E Matichard

4

1 reference

15 August 2017

R Meziani

5

1 reference

15 August 2017

D Mirebeau

6

1 reference

15 August 2017

V Descamps

7

1 reference

15 August 2017

B Gérard

8

1 reference

15 August 2017

A Archimbaud

9

1 reference

15 August 2017

L Ollivaud

10

1 reference

15 August 2017

F Bouscarat

11

1 reference

15 August 2017

M Baccard

12

1 reference

15 August 2017

G Lanternier

13

1 reference

15 August 2017

P Saïag

14

1 reference

15 August 2017

C Lebbé

15

1 reference

15 August 2017

N Basset-Seguin

16

1 reference

15 August 2017

B Crickx

17

1 reference

15 August 2017

H Cave

18

1 reference

15 August 2017

B Grandchamp

19

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

90

1 reference

15 August 2017

2

1 reference

15 August 2017

503-509

1 reference

Genetic testing for melanoma.

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

A melanoma-associated germline mutation in exon 1beta inactivates p14ARF.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

Recent advances in melanoma research

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

New developments in melanoma genetics

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

Association between INK4a-ARF and p53 mutations in skin carcinomas of xeroderma pigmentosum patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

The Pezcoller lecture: cancer cell cycles revisited

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

Melanoma genetics: an update with focus on the CDKN2A(p16)/ARF tumor suppressors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

The genetics of hereditary melanoma and nevi. 1998 update

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

Regulation of p53 stability

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: A consensus statement of the Melanoma Genetics Consortium

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

Complete scanning of the CDK4 gene by denaturing gradient gel electrophoresis: a novel missense mutation but low overall frequency of mutations in sporadic metastatic malignant melanoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

Germline p16 mutations in familial melanoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

A simple salting out procedure for extracting DNA from human nucleated cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

Adenovirus-mediated p14(ARF) gene transfer in human mesothelioma cells

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

Inactivations of p16INK4a-alpha, p16INK4a-beta and p15INK4b genes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced murine lymphomas

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility allele.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

Functional impairment of melanoma-associated p16(INK4a) mutants in melanoma cells despite retention of cyclin-dependent kinase 4 binding.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

Interaction of glutathione S-transferase M1 and T1 genotypes and malignant melanoma.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

Mutation screening of the CDKN2A promoter in melanoma families.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

Functional evidence for a role of combined CDKN2A (p16-p14(ARF))/CDKN2B (p15) gene inactivation in malignant gliomas.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

CDKN2A germline mutations in U.K. patients with familial melanoma and multiple primary melanomas

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2409576

The melanocortin-1-receptor gene is the major freckle gene

5 September 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601503

Germline Mutations of the CDKN2 Gene in UK Melanoma Families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601503

CDKN2A Variants in a Population-Based Sample of Queensland Families With Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601503

Sporadic multiple primary melanoma cases:CDKN2Agermline mutations with a founder effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601503

Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4Mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601503

Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601503

Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group [published erratum appears in Hum Mol Genet 1998 May;7(5):941]

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601503

Melanocortin 1 Receptor (MC1R) Gene Variants are Associated with an Increased Risk for Cutaneous Melanoma Which is Largely Independent of Skin Type and Hair Color

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601503

Mutations in theINK4a/ARFMelanoma Susceptibility Locus Functionally Impair p14ARF

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601503

CDKN2A mutations in multiple primary melanomas

21 January 2018

1 reference

12 December 2020

A single nucleotide polymorphism in the 3?untranslated region of theCDKN2A gene is common in sporadic primary melanomas but mutations in theCDKN2B,CDKN2C,CDK4 andp53 genes are rare

1 reference

12 December 2020

Rarity of CDK4 germline mutations in familial melanoma

1 reference

12 December 2020

Germline CDKN2A mutation implicated in predisposition to multiple myeloma

1 reference

12 December 2020

Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations

1 reference

12 December 2020

High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families

1 reference

12 December 2020

Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma

1 reference

12 December 2020

CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas

1 reference

12 December 2020

The CDKN2A tumour suppressor gene: no mutations detected in patients with melanoma and additional unrelated cancers

1 reference

12 December 2020

p16 gene homozygous deletions in acute lymphoblastic leukemia

1 reference

12 December 2020

MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p

1 reference

12 December 2020

Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds

1 reference

12 December 2020

Epidemiology and prognosis of subungual melanoma in 34 Japanese patients

1 reference

12 December 2020

Familial tumor syndrome associated with a germline nonfunctional p16INK4a allele

1 reference

12 December 2020

Germline CDKN2A mutations in childhood melanoma

1 reference

12 December 2020

CDKN2A (P16(INK4a)) and CDK4 mutation analysis in 131 Australian melanoma probands: effect of family history and multiple primary melanomas

1 reference

12 December 2020

Cytochrome P450 CYP2D6 genotypes: association with hair colour, Breslow thickness and melanocyte stimulating hormone receptor alleles in patients with malignant melanoma

1 reference

12 December 2020

Mutation screening of theCDKN2A promoter in melanoma families

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601503

7 January 2021

inferred from DOI database lookup

Locoregional treatment of low-grade B-cell lymphoma with CD3xCD19 bispecific antibodies and CD28 costimulation. II. Assessment of cellular immune responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601503

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/SJ.BJC.6601503

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

PubMed publication ID

14735200

1 reference